Please assess the completion status of the following clinical trial:

Trial Title: Rosuvastatin in the Long-term Treatment of Hypercholesterolaemic Subjects With Coronary Heart Disease

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Signed written informed consent,~* 20 to 75 years old,~* Plan to undergo coronary angiography (CAG) or Percutaneous coronary intervention (PCI) and LDL-C ≥ 140 mg/dL (untreated patients) or LDL-C ≥ 100 mg/dL (treated patients)~Exclusion Criteria:~* Acute myocardial infarction within 72 hours after the onset,~* Heart failure of New York Heart Association (NYHA) Class III or above,~* Serious arrhythmia,~* Being treated with LDL-apheresis~* History of serious reaction or hypersensitivity to other HMG-CoA reductase inhibitors.

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).